Evaluation and management of cholesterol embolization and the blue toe syndrome

Current Opinion in Cardiology

Volumn 11, Issue 5, 1996, Pages 533-542

  Applebaum, Robert M ^a   Kronzon, Itzhak ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ANGIOGRAPHY; ARTERY OCCLUSION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; ECHOGRAPHY; EMBOLISM; HUMAN; ISCHEMIA; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; THORACIC AORTA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0029742784     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199609000-00013     Document Type: Review

References (66)

1. Baumann DS, Sicard GA: Atheroembolism. In Vascular Surgery Theory • and Practice, edn 1. Edited by Callow AD, Ernst CB. Stamford, CT: Appleton and Lange; 1995:1139-1144. Very good concise summary of the disorder from a surgical perspective.
2. Kaufman JL, Shah DM, Leather RP: Atheroembolism and microthrom•• boembolic syndromes (blue toe syndrome and disseminated atheroembolism). In Vascular Surgery, edn 4. Edited by Rutherford RB. Philadelphia: WB Saunders Company; 1995:669-676. Very comprehensive review of the subject, with particular emphasis on the pathophysiology.
3. Colt HG, Begg RJ, Saporito JJ, Cooper WM, Shapiro AP: Cholesterol emboli after cardiac catheterization: eight cases and a review of the literature. Medicine 1988, 67:389-400.
4. Fine, MJ, Kapoor W, Falanga V: Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology 1987, 38:769-784.
5. Rosansky SJ, Deschamps EG: Multiple cholesterol emboli syndrome after angiography. Am J Med Sci 1984, 288:45-48.
6. Panum PL: Experimentelle beitrage zue hehre von der embolie. Virchows Arch Pathol Anat 1862, 25:308-310.
7. Flory CM: Arterial occlusion produced by embolism from eroded atheromatous plaque. Am J Pathol 1945, 21:549-565.
8. Gore I, McCombs HL, Lindquist RL: Observations on the fate of cholesterol emboli. J Atheroscler Res 1964, 4:527-535.
9. Baumann DS, McGraw D, Rubin BG, Allen BT, Andersen CB, Sicard GA: An institutional experience with arterial atheroembolism. Ann Vasc Surg 1994, 8:258-265.
10. Copeman PWM: Signs in the skin of disturbance of blood viscosity and of blood flow. Br J Dermatol 1975, 93:519-529.
11. Rosman HS, Davis TP, Reddy D, Goldstein S: Cholesterol embolization: clinical findings and implications. J Am Coll Cardiol 1990, 15:1296-1299.
12. Cosio FG, Zager RA, Sharma HM: Atheroembolic renal disease causes hypocomplementemia. Lancet 1985, ii:118-121.
13. Dalakos TG, Streeten DHP, Jones D, Obeid A: "Malignant" hypertension resulting from atheromatous embolization predominantly of one kidney. Am J Med 1974, 57:135-138.
14. Kasinalh BS, Corwin HL, Bidani AK, Korbet SM, Schwartz MM, Lewis EJ: Eosinophilia in the diagnosis of atheroembolic renal disease. Am J Nephrol 1987, 7:173-177.
15. Cogan E, Schandene L, Papadopoulos T, Crusiaux A, Goldman M: Interleukin-5 production by T lymphocytes in atheroembolic disease with hypereosinophilia. J Allergy Clin Immunol 1995, 96:427-429.
16. Darsee JR: Cholesterol embolism: the great masquerader. South Med J 1978, 72:174-180.
17. Hyman BT, Landas SK, Ashman RF, Schelper RL, Robinson RA: Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med 1987, 82:1233-1237.
18. Kealy WF: Atheroembolism. J Clin Pathol 1978, 31:984.
19. Ramirez G, O'Neill WM, Lambert R, Bloomer A: Cholesterol embolization: a complication of angiography. Arch Intern Med 1978, 138:1430-1432.
20. Dahlberg PJ, Frecentese DF, Cogbill TH: Cholesterol embolism: experience with 22 histologically proven cases. Surgery 1989, 105:737-746.
21. Holly DC, Zachary PE: Cholesterol embolization leading to small and large bowel Infarction. Am J Gastroenterol 1995, 90:2075-2076.
22. Turnbull RG, Hayashi AH, McLean DR: Multple spontaneous intestinal perforations from atheroemboli after thrombolytic therapy: a case report Can J Surg 1994, 37:325-328.
23. Orvar K, Johlin FC: Atheromatous embolization resulting in acute pancreatitis after cardiac catheterization and angiographic studies. Arch Intern Med 1994, 154:1755-1761.
24. Hollenhurst RW: Significance of bright plaques in the retinal arterioles. JAMA 1961, 178:123-129.
25. Slavin RE, Gonzales-Vitale JC, Martin OS: Atheromatous emboli to the lumbosacral spinal chord. Stroke 1975, 6:411-416.
26. Keen RR, McCarthy WJ, Shireman PK, Feinglass J, Pearce WH, Durham •• JR, Yao JST: Surgical management of atheroembolization. J Vasc Surg 1995, 21:773-781. Large prospective series studying various surgical techniques to prevent further embolization and the effect on outcome.
27. Feder W, Auerbach R: "Purple toes" an uncommon sequela of oral coumadin drug therapy. Ann Intern Med 1961, 55:911-917.
28. Moldveen-Geronimus M, Merriam JC Jr: Cholesterol embolization from pathological curiosity to clinical entity. Circulation 1967, 35:946-953.
29. Bruns FJ, Segel DP, Adler S: Case report control of cholesterol embolization by discontinuation of anticoagulant therapy. Am J Med Sci 1978, 275:105-108.
30. Schwartz MW, McDonald GB: Cholesterol embolization syndrome occurrence after intravenous streptokinase therapy for myocardial infarction. JAMA 1987, 258:1934-1935.
31. Ridiker PM, Michel T: Streptokinase therapy and cholesterol embolization. Am J Med 1989, 87:357-358.
32. Shapiro LS: Cholesterol embolization after treatment with tissue plasminogen activator. N Engl J Med 1989, 321:1270.
33. Gupta BK, Spinowitz BS, Charytan C, Wahl SJ: Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasiminogen activator. Am J Kidney Dis 1993, 21:659-662.
34. Ben-Chitrit S, Korzets Z, Hershkovitz R, Bernheim J, Schneider M, Bernheim J: Cholesterol embolization syndrome following thrombolytic therapy with Streptokinase and tissue plasminogen activator. Nephrol Dial Transplant 1994, 9:428-430.
35. Blakenship JC, Butler M, Garbes, A: Prospective assessment of choles• terol embolization in patients with acute myocardial infarction treated with thrombolytic vs conservative therapy. Chest 1995, 107:662-668. This prospective study, which tried to answer the question "does thrombolytic therapy promote atheroembolism?" suffers from a small sample size and the fact that all patients underwent cardiac catheterization, which can itself promote cholesterol embolization.
36. Gaines PA, Kennedy A, Moorhead P, Cumberland DC, Welsh CL, Rutley MS: Cholesterol embolisation: a lethal complication of vascular catheterisation. Lancet 1988, i:168-170.
37. Drost H, Buis B, Han D, Hillers JA: Cholesterol embolism as a complication of left heart catheterisation: report of seven cases. Br Heart J 1984, 52:339-442.
38. Karmody AM, Powers SR, Monaco VJ, Leather RP: "Blue toe" syndrome, an indication for limb salvage surgery. Arch Surg 1976, 111:1263-1268.
39. Kaufman JL, Stark K, Brolin RE: Disseminated atheroembolism from extensive degenerative atherosclerosis of the aorta. Surgery 1987, 102:63-70.
40. Kronzon I, Tunick PA: Transesophageal echocardiography as a tool in the evaluation of patients with embolic disorders. Prog Cardiovasc Dis 1993, 36:39-60.
41. Kronzon I, Tunick PA: Aortic atheromas. In Cardiogenic Embolism, edn 1. •• Edited by Daniel WG, Kronzon I, Mugge A. Baltimore: Williams and Wilkins; 1996: 177-187. Comprehensive review of aortic atheromas and especially their risk of embolization, as defined by the TEE study.
42. Katz ES, Tunick PA, Rusinek H, Ribakove G, Spencer FC, Kronzon I: Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass: experience with intraoperative transesophageal echocardiography. J Am Coll Cardiol 1992, 20:70-77.
43. Tunick PA, Kronzon I: Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization: a new finding seen by transesophageal echocardiography. Am Heart J 1990, 120:658-660.
44. Simmons AJ, Carlson R, Hare CL, Obeid Al, Smulyan H: The use of transesophageal echocardiography in detecting aortic atherosclerosis in patients with embolic disease. Am Heart J 1992, 123:224-226.
45. Koppang JR, Nanda NC, Coghlan C, Sanyal R: Histologically confirmed cholesterol atheroemboli with identification of the source by transesophageal echocardiography. Echocardiography 1992, 9:379-383.
46. Coy KM, Maurer G, Goodman D, Siegel RJ: Transesophageal echocardiographic detection of aortic atheromatosis may provide clues to occult renal dysfunction in the elderly. Am Heart J 1992, 123:1684-1686.
47. Karalis DG, Chandrasekaran K, Victor MF, Ross JJ Jr, Mintz GS: Recognition and embolic potential of intraaortic atherosclerotic debris. J Am Coll Cardiol 1991, 17:73-78.
48. Tunick PA, Kronzon I: The improved yield of transesophageal echocardiography in patients with neurologic events is in large due to detection of aortic arch protruding atheromas. Echocardiography 1992, 9:491-495.
49. Rubin DC, Plotnick GD, Hawke MW: Intraaortic debris as a potential source of embolic stroke. Am J Card 1992, 69:819-820.
50. Tunick PA, Perez JL, Kronzon I: Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med 1991, 115:423-427.
51. Tunick PA, Rosenzweig BP, Katz ES, Freedberg RS, Perez JL, Kronzon I: High risk for vascular events in patients with protruding atheromas: a prospective study. J Am Coll Cardiol 1994, 23:1085-1090.
52. Amarenco P, Duyckaerts C, Tzourio C, Henin D, Bousser MG, Jauw JJ: Prevalence of ulcerated plaques In the aortic arch in patients with stroke. N Engl J Med 1992, 326:221-225.
53. Khatibzadeh M, Mitusch R, Stierle U, Gromoll B, Sheikhzadeh A: Aortic •• atherosclerotic plaques as a source of systemic embolization. J Am Coll Cardiol 1996, 27:664-669. Large prospective trial showing the association between systemic embolization and complicated aortic plaques seen on TEE.
54. Culliford AT, Tunick PA, Katz ES, Kronzon I, Galloway AC, Ribakove GH, Esposito RA, Spencer FC: Initial experience with removal of protruding atheroma from the transverse arch: diagnosis by transesophageal echo, operative technique, and follow up [abstract]. J Am Coll Cardiol 1993, 21:342A.
55. Tunick PA, Culliford AT, Lamparello P, Kronzon I: Atheromatosis of the aortic arch as an occult source of multiple systemic emboli. Ann Intern Med 1991, 114:391-392.
56. Tunick PA, Lackner H, Katz ES, Culliford AT, Kronzon I: Multiple emboli from a large aortic thrombus in a patient with thrombotic diathesis. Am Heart J 1992, 124:239-241.
57. Nihoyannopoulos P, Joshi J, Athanasopoulous G, Oakely CM: Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am J Cardiol 1993, 71:1028-1212.
58. Freedberg RS, Tunick PA, Culliford AT, Tatelbaum RJ, Kronzon I: Disappearance of a large intra-aortic mass in a patient with prior systemic embolization. Am Heart J 1993, 125:1445-1447.
59. Bansal RC, Pauls GL, Shankel SW: Blue digit syndrome: transesophageal echocardiographic identification of thoracic aortic plaque-related thrombi and successful outcome with warfarin. J Am Soc Echocardiogr 1993, 6: 319-323.
60. Hausmann D. Gulba D, Bargheer K, Niedermeyer J, Comess KA, Daniel WG: Successful thrombolysis of an aortic arch thrombus in a patient after mesenteric embolism. N Engl J Med 1992, 327:500-501.
61. Friedman SG, Krishnasastry KV: External Iliac ligation and axillary bifemoral bypass for blue toe syndrome. Surgery 1994, 115:27-30.
62. Morris-Jones W, Preston FE, Greaney M, Chatterjee DK: Gangrene of the toes with palpable peripheral pulses, response to platelet suppressive therapy. Ann Surg 1981, 193:462-466.
63. Wingo JP, Nix ML, Greenfield LJ, Barnes RW: The blue toe syndrome: hemodynamics and therapeutic correlates of outcome. J Vasc Surg 1986, 3:475-480.
64. Kumpe DA, Zwerdlinger S, Griffin DJ: Blue digit syndrome: treatment with percutaneous transluminal angioplasty. Radiology 1988, 166:37-44.
65. Brewer ML, Kinnison ML, Perler BA, White RI: Blue toe syndrome: treatment with anticoagulants and delayed percutaneous angioplasty. Radiology 1988, 166:31-36.
66. Cabili S, Hochman I, Goor Y: Reversal of gangrenous lesions in the blue toe syndrome with lovastatin: a case report Angiology 1993, 44:821-825.